Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamineD1 and serotonin2 receptors and is targeted to tachykinin neurons of the dorsomedial striatum

Neuroscience

Volumn 105, Issue 3, 2001, Pages 671-680

  Campbell, B M ^a   Gresch, P J ^a   Walker, P D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Basal ganglia; Enkephalin; Gene expression; In situ hybridization; Neuropeptide; Substance P

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 PHENYL 1H 3 BENZAZEPINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; MESSENGER RNA; PREPROENKEPHALIN; PREPROTACHYKININ; RITANSERIN; SEROTONIN 2 AGONIST; SEROTONIN 2 ANTAGONIST; TACHYKININ;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEPLETION; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DYSKINESIA; GENE CONTROL; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

3,4-DIHYDROXYPHENYLACETIC ACID; AGING; ANIMALS; ANIMALS, NEWBORN; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DRUG SYNERGISM; ENKEPHALINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MOVEMENT DISORDERS; NEOSTRIATUM; NEURONS; OXIDOPAMINE; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, SEROTONIN; RNA, MESSENGER; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; TACHYKININS;

EID: 0035882124     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00218-4     Document Type: Article

References (42)

1. A pre- and postsynaptic modulatory action of 5-HT and the 5-HT2A, 2C receptor agonist DOB on NMDA-evoked responses in the rat medial prefrontal cortex
2. Serotonin 2A receptor mRNA levels in the neonatal dopamine depleted rat striatum remain upregulated following suppression of serotonin hyperinnervation
3. Stimulated serotonin release from hyperinnervated terminals subsequent to neonatal dopamine depletion regulates striatal tachykinin, but not enkephalin gene expression
4. A complex program of striatal gene expression induced by dopaminergic stimulation
5. Behavioral differences between neonatal and adult 6-hydroxydompamine-treated rats to dopamine agonists: Relevance to neurological symptoms in clinical syndromes with reduced brain dopamine
6. Evidence that D1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dehydroxyphenylalanine in rats treated with 6-hydroxydopamine
7. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: Functional supersensitivity of D1 dopamine receptors in neonatally lesioned rats
8. Selective increases in serotonin 5-HT1B/1D and 5-HT2A/CA/2C binding sites in adult rat basal ganglia following lesions of serotonergic neurons
9. Effects of MK-801 on D1 dopamine receptor-mediated immediate-early gene expression in the dopamine-depleted striatum
10. Interaction between the serotonergic and dopaminergic systems in d-fenfluramine-induced activation of c-fos and jun B genes in rat striatal neurons
11. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons
12. Dopamine and serotonin interactions in the modulation of the expression of the immediate-early transcription factor, nerve growth factor-inducible B, in the striatum
13. Acute p-chloroamphetamine increases striatal preprotachykinin mRNA: Role of the serotonin 2A/2C receptor
14. Serotonin-2 receptor stimulation normalizes striatal preprotachykinin mRNA in an animal model of Parkinson's disease
15. Synergistic interaction between Serotonin-2 receptor and dopamine D1 receptor stimulation on striatal preprotachykinin mRNA expression in the 6-hydroxydopamine lesioned rat
16. Dopamine D-1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway
17. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A
18. Dopamine receptor agonists regulate levels of the serotonin 5-HT2A receptor and its mRNA in a subpopulation of rat striatal neurons
19. D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum
20. Serotonin2/1C receptor activation causes a localized expression of the immediate-early gene c-fos in rat brain: Evidence for involvement of dorsal raphe nucleus projection fibers
21. Colocalization of D1 and D2 dopamine receptor mRNAs in striatal neurons
22. Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein
23. Neuropeptide gene expression in brain is differentially regulated by midbrain dopamine neurons
24. Protein measurement with the Folin phenol reagent
25. Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine- and adensosine 3′:5′-monophosphate-regulated (DARP-32) immunoreactivity
26. Studies on brain monoamine and neuropeptide systems after neonatal intracerbroventricular 6-hydroxydopamine treatment
27. Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: Comparison with acute haloperidol effects
28. Serotonin 5-HT1 and 5-HT2A/C receptors in adult rat brain after neonatal destruction of nigrostriatal dopamine neurons: A quantitative autoradiographic study
29. Fenfluramine-induced activation of the immediate-early gene c-fos in the striatum: Possible interaction between serotonin and dopamine
30. Interactions between D1 and muscarinic receptors in the induction of striatal c-fos in rats depleted of dopamine as neonates
31. DOI-induced activation of the cortex: Dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons
32. Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression
33. Dopamine-dependent postnatal development of enkephalin and tachykinin neurons of rat basal ganglia
34. Serotonergic regulation of striatal dynorphin and substance P systems: A study with serotonin uptake inhibitor fluoxetine
35. C-fos gene expression is induced in a subpopulation of striatal neurons following a single administration of a dopamine D1-receptor agonist in adult rats lesioned with 6HD as neonates
36. Apparent sprouting of striatal serotonergic terminals after dopamine-depleting lesions in neonatal rats
37. Preprotachykinin and preproenkephalin mRNA expression within striatal subregions in response to altered serotonin transmission
38. Serotonin regulation of tachykinin biosynthesis in the rat neostriatum
39. D1 and D2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine
40. Colocalization of serotonin subtypes 5-HT2A/CA, 5-HT2A/CC, and 5-HT6 with neuropeptides in the rat striatum
41. Rat brain preproenkephalin mRNA